glucagon-like peptide-1 gene therapy (TKT)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameglucagon-like peptide-1 gene therapy (TKT)
Drug Alias NameGLP-1 gene therapy (TKT)diabetes gene therapy (TKT)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire Human Genetic Therapies, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Human Genetic Therapies, Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A